Approval · Notice of Compliance 9682 · 2008
FASTURTEC: Notice of Compliance 9682
Issued July 17, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9682
- Date
- July 17, 2008
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Transfer of drug substance manufacturing site
- Therapeutic class
- Uricolytic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FASTURTEC | Not yet assigned | — |
Medicinal ingredients
- RASBURICASE 1.5 MG per VIAL
- RASBURICASE 7.5 MG per VIAL